About 60,688 results

ALLMedicine™ Diarrhea Center

Research & Reviews  15,343 results

Antibiotic Use and Stewardship Practices in a Pediatric Community-Based Cohort Study in...
Clinical Infectious Diseases : an Official Publication Of... Schiaffino F, Colston JM et. al.

Jun 25th, 2022 - There is a need to evaluate antibiotic use, duration of therapy and stewardship in low- and middle-income countries to guide the development of appropriate stewardship programs that are global in scope and effectively decrease unnecessary antibiot...

The role of gastrointestinal pathogen PCR testing in liver transplant recipients hospit...
Transplant Infectious Disease : an Official Journal of Th... Ching CK, Nobel YR et. al.

Jun 25th, 2022 - Diarrhea is a common symptom among liver transplant (LT) recipients and can result in significant morbidity. The utility of PCR-based multiplex gastrointestinal (GI) pathogen panels in this population is unknown. We assessed incidence, predictors,...

The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel FOLFOX-A fo...
American Journal of Clinical Oncology; Breakstone R, Almhanna K et. al.

Jun 25th, 2022 - To evaluate response rate, toxicity, and efficacy of the novel combination of nab-paclitaxel, oxaliplatin, 5-fluorouracil, and leucovorin [FOLFOX-A] in patients with advanced pancreatic ductal adenocarcinoma [PDAC]. BrUOG-292 and BrUOG-318 were tw...

Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11,...
Fetal and Pediatric Pathology; He M, Wong A et. al.

Jun 25th, 2022 - A small subset of cases of inflammatory bowel disease (IBD) occurs as a result of single gene defects, and typically occurs in young or very young pediatric patients, referred to as "monogenic very-early onset IBD (VEO-IBD)". The gene variants lea...

see more →

Guidelines  18 results

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Sy...
Gastroenterology Lembo A, Sultan S et. al.

Jun 24th, 2022 - Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of ...

ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides diffici...
https://doi.org/10.14309/ajg.0000000000001278 10.1016/j.cgh.2020.06.051
The American Journal of Gastroenterology; Kelly CR, Fischer M et. al.

May 19th, 2021 - Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent ...

AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.
Gastroenterology Quigley EM, Murray JA et. al.

Jul 18th, 2020 - Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implica...

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
Journal of the National Comprehensive Cancer Network : JN... Thompson JA, Schneider BJ et. al.

Mar 7th, 2020 - The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe sympt...

Antimotility agents for the treatment of acute noninfectious diarrhea in critically ill...
The Journal of Trauma and Acute Care Surgery; Bugaev N, Bhattacharya B et. al.

Oct 2nd, 2019 - Acute noninfectious diarrhea is a common phenomenon in intensive care unit patients. Multiple treatments are suggested but the most effective management is unknown. A working group of the Eastern Association for the Surgery of Trauma, aimed to eva...

see more →

Drugs  2,075 results see all →

Clinicaltrials.gov  1,796 results

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

Jun 24th, 2022 - Background: Irinotecan is a prodrug of an inhibitor of topoisomerase 1 (active metabolite is SN-38) with known activity in sarcomas, however it has limitations including suboptimal bioavailability and systemic side effects including severe diarrhe...

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Jun 24th, 2022 - PRIMARY OBJECTIVES: I. To compare the efficacy of infliximab and vedolizumab for clinical remission/response of immune-related diarrhea and/or colitis. II. To assess the safety and tolerability of the treatment for immune-mediated diarrhea and/or ...

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Jun 24th, 2022 - Systemic mastocytosis is a disorder caused by clonal mast cell proliferation and release of mast cell mediators including tryptase. As a result, mast cell numbers may increase and affect target organs including the dermis (maculopapular cutaneous ...

A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations

Jun 23rd, 2022 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

Vitamin D Levels in Umbilical Cord and It's Impact on Infant and Children's Health (VITADi Study)

Jun 23rd, 2022 - Participants of this study are women in the third semester of pregnancy, who consented to be included with their babies in this study. Firstly, the parents will be given explanation regarding the study, and informed consent will be signed if they ...

see more →

News  4,763 results

Pharmacologic Treatment of IBS: AGA Clinical Practice Guidelines

Jun 24th, 2022 - The American Gastroenterological Association has issued new guidelines for the medical treatment of irritable bowel syndrome (IBS). The guidelines, which are separated into one publication for IBS with constipation (IBS-C) and another for IBS with...

AGA Clinical Practice Guidelines: Pharmacologic treatment of IBS
Will Pass

Jun 22nd, 2022 - The American Gastroenterological Association has issued new guidelines for the medical treatment of irritable bowel syndrome (IBS). The guidelines, which are separated into one publication for IBS with constipation (IBS-C) and another for IBS with.

Multispecies Probiotic May Help Prevent Diarrhea in Kids on Antibiotics

Jun 22nd, 2022 - NEW YORK (Reuters Health) - A probiotic containing eight different strains of live beneficial microorganisms may help prevent diarrhea during antibiotic treatment in children, according to a randomized, placebo-controlled study. The results are in...

5 Things to Know About Ehrlichiosis and Anaplasmosis

Jun 21st, 2022 - Ehrlichiosis and anaplasmosis are emerging but underrecognized tickborne diseases in the United States. In the United States, three pathogens cause human ehrlichiosis: Ehrlichia chaffeensis, E ewingii, and E muris eauclairensis. Anaplasmosis is ca...

Diarrhea and weight loss

Jun 16th, 2022 - On the basis of the patient's presentation and history, this is probably a case of Crohn disease. Considering that the age of onset of Crohn disease has a bimodal distribution, this case is representative of late-onset disease.

see more →

Patient Education  280 results see all →